Author Question: Consider an apple orchard owner deciding how to incentivize his fruit pickers. He pays per pound ... (Read 202 times)

vicky

  • Hero Member
  • *****
  • Posts: 586
Consider an apple orchard owner deciding how to incentivize his fruit pickers. He pays per pound harvested but adjusts the compensation rate higher during poor harvest seasons. As a consequence
 a. The compensation rate should be fixed at all times
 b. The pickers might try to game the system by discouraging others from harvesting too much
 c. The pickers would claim good harvests in order to be paid higher piece rates even during poor harvest seasons
  d. None of the above

Question 2

Break-even quantity is a point where
 a. Level of profit is maximized
  b. Level of cost is minimized
  c. Only variable costs are covered
  d. There is neither a profit nor a loss



Eazy416

  • Sr. Member
  • ****
  • Posts: 360
Answer to Question 1

b

Answer to Question 2

d



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Adults are resistant to the bacterium that causes Botulism. These bacteria thrive in honey – therefore, honey should never be given to infants since their immune systems are not yet resistant.

Did you know?

Parkinson's disease is both chronic and progressive. This means that it persists over a long period of time and that its symptoms grow worse over time.

Did you know?

Many people have small pouches in their colons that bulge outward through weak spots. Each pouch is called a diverticulum. About 10% of Americans older than age 40 years have diverticulosis, which, when the pouches become infected or inflamed, is called diverticulitis. The main cause of diverticular disease is a low-fiber diet.

Did you know?

Complications of influenza include: bacterial pneumonia, ear and sinus infections, dehydration, and worsening of chronic conditions such as asthma, congestive heart failure, or diabetes.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library